AdaptHealth (NASDAQ:AHCO) Releases Earnings Results, Misses Estimates By $1.10 EPS

AdaptHealth (NASDAQ:AHCO) posted its quarterly earnings data on Tuesday. The company reported ($0.76) EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($1.10), FiscalAI reports. AdaptHealth had a net margin of 2.53% and a return on equity of 4.85%. The firm had revenue of $846.29 million during the quarter, compared to the consensus estimate of $832.51 million. During the same period in the prior year, the company posted $0.34 earnings per share. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year.

AdaptHealth Trading Down 0.5%

NASDAQ AHCO opened at $10.29 on Tuesday. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 1.09. AdaptHealth has a 52 week low of $7.11 and a 52 week high of $11.63. The business has a 50 day moving average price of $10.27 and a 200-day moving average price of $9.67. The company has a market cap of $1.39 billion, a price-to-earnings ratio of 18.71, a P/E/G ratio of 1.18 and a beta of 1.72.

Insider Transactions at AdaptHealth

In related news, Director David Solomon Williams III sold 5,000 shares of AdaptHealth stock in a transaction on Thursday, December 4th. The shares were sold at an average price of $9.43, for a total value of $47,150.00. Following the completion of the sale, the director owned 45,045 shares of the company’s stock, valued at approximately $424,774.35. This trade represents a 9.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.55% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Corient Private Wealth LLC raised its position in AdaptHealth by 8.6% in the 4th quarter. Corient Private Wealth LLC now owns 22,562 shares of the company’s stock valued at $227,000 after buying an additional 1,794 shares during the last quarter. Adage Capital Partners GP L.L.C. purchased a new stake in shares of AdaptHealth in the second quarter valued at about $189,000. Jump Financial LLC bought a new position in shares of AdaptHealth during the second quarter valued at about $181,000. Vident Advisory LLC lifted its position in shares of AdaptHealth by 17.9% during the second quarter. Vident Advisory LLC now owns 17,737 shares of the company’s stock valued at $167,000 after purchasing an additional 2,694 shares in the last quarter. Finally, EntryPoint Capital LLC boosted its holdings in AdaptHealth by 24.6% during the fourth quarter. EntryPoint Capital LLC now owns 15,919 shares of the company’s stock worth $159,000 after purchasing an additional 3,142 shares during the last quarter. 82.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have commented on AHCO. Zacks Research raised shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 1st. Wall Street Zen downgraded AdaptHealth from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Canaccord Genuity Group upped their target price on AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Finally, Weiss Ratings raised AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, January 30th. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $14.25.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.